San Diego, CA -- (SBWIRE) -- 08/18/2017 -- An investigation for investors in NASDAQ:MDXG shares was announced concerning possible breaches of fiduciary duties by certain directors.

Investors who purchased shares of MiMedx Group Inc (NASDAQ:MDXG) should contact the Shareholders Foundation at mail(at)shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain MiMedx Group directors breached their fiduciary duties and caused damage to the company and its shareholders.

Marietta, GA based MiMedx Group, Inc. is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants human placental tissue, skin and bone

MiMedx Group Inc reported that its annual Total Revenue rose from $187.30 million in 2015 to $245.01 million in 2016 and that its Net Income declined from $29.45 million in 2105 to $11.97 million in 2016.

Shares of MiMedx Group Inc (NASDAQ:MDXG) grew from $6.74 per share in May 2016 to as high as $17.36 per share on August 16, 2017

Those who purchased shares of MiMedx Group Inc (NASDAQ:MDXG), have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com